| # | Pathway | Proteins |
|---|
| 1 | Protein digestion and absorption | ENSAPLP00000000463, ENSAPLP00000008210, ENSAPLP00000001783, ENSAPLP00000009420, ENSAPLP00000000439, ENSAPLP00000005210 |
| 2 | Vitamin digestion and absorption | ENSAPLP00000011529, ENSAPLP00000003561, ENSAPLP00000016339 |
| 3 | Malaria | ENSAPLP00000016307, ENSAPLP00000007488, ENSAPLP00000005443 |
| 4 | Fat digestion and absorption | ENSAPLP00000011529, ENSAPLP00000003561, ENSAPLP00000016339 |
| 5 | PI3K-Akt signaling pathway | ENSAPLP00000000463, ENSAPLP00000002091, ENSAPLP00000001783, ENSAPLP00000004439, ENSAPLP00000009420, ENSAPLP00000001716, ENSAPLP00000000439, ENSAPLP00000005210 |
| 6 | African trypanosomiasis | ENSAPLP00000016307, ENSAPLP00000007488, ENSAPLP00000005443 |
| 7 | ECM-receptor interaction | ENSAPLP00000000463, ENSAPLP00000001783, ENSAPLP00000009420, ENSAPLP00000000439, ENSAPLP00000005210 |
| 8 | Amoebiasis | ENSAPLP00000012216, ENSAPLP00000007789, ENSAPLP00000004168, ENSAPLP00000009420, ENSAPLP00000013412 |
| 9 | Systemic lupus erythematosus | ENSAPLP00000011395, ENSAPLP00000001729, ENSAPLP00000004168, ENSAPLP00000001720 |
| 10 | Alcoholism | ENSAPLP00000011395, ENSAPLP00000001729, ENSAPLP00000001720, ENSAPLP00000001716 |
| 11 | Focal adhesion | ENSAPLP00000000463, ENSAPLP00000003837, ENSAPLP00000001783, ENSAPLP00000009420, ENSAPLP00000000439, ENSAPLP00000005210 |
| 12 | Butirosin and neomycin biosynthesis | ENSAPLP00000009741 |
| 13 | Complement and coagulation cascades | ENSAPLP00000010484, ENSAPLP00000006069, ENSAPLP00000003063 |
| 14 | Nitrogen metabolism | ENSAPLP00000002717 |
| 15 | PPAR signaling pathway | ENSAPLP00000004409, ENSAPLP00000006229 |
| 16 | Synthesis and degradation of ketone bodies | ENSAPLP00000010177 |
| 17 | Carbohydrate digestion and absorption | ENSAPLP00000009741 |
| 18 | Proximal tubule bicarbonate reclamation | ENSAPLP00000002717 |
| 19 | Proteoglycans in cancer | ENSAPLP00000013972, ENSAPLP00000003837, ENSAPLP00000004439, ENSAPLP00000013792 |
| 20 | Type II diabetes mellitus | ENSAPLP00000009741 |
| 21 | Neuroactive ligand-receptor interaction | ENSAPLP00000004168 |
| 22 | Dorso-ventral axis formation | ENSAPLP00000016323 |
| 23 | Collecting duct acid secretion | ENSAPLP00000002717 |
| 24 | Renin-angiotensin system | ENSAPLP00000004168 |
| 25 | Bile secretion | ENSAPLP00000002717 |
| 26 | Bladder cancer | ENSAPLP00000013972 |
| 27 | Notch signaling pathway | ENSAPLP00000016323 |
| 28 | Hepatitis B | ENSAPLP00000002091, ENSAPLP00000013972 |
| 29 | Viral carcinogenesis | ENSAPLP00000015706, ENSAPLP00000002091, ENSAPLP00000001720 |
| 30 | HIF-1 signaling pathway | ENSAPLP00000004439, ENSAPLP00000009741 |
| 31 | Olfactory transduction | ENSAPLP00000001716 |
| 32 | Pathogenic Escherichia coli infection | ENSAPLP00000002091, ENSAPLP00000015503 |
| 33 | Mineral absorption | ENSAPLP00000009906 |
| 34 | Metabolism of xenobiotics by cytochrome P450 | ENSAPLP00000005537 |
| 35 | Drug metabolism - cytochrome P450 | ENSAPLP00000005537 |
| 36 | mTOR signaling pathway | ENSAPLP00000004439 |
| 37 | Butanoate metabolism | ENSAPLP00000010177 |
| 38 | Galactose metabolism | ENSAPLP00000009741 |
| 39 | Fructose and mannose metabolism | ENSAPLP00000009741 |
| 40 | Chemical carcinogenesis | ENSAPLP00000005537 |
| 41 | Insulin signaling pathway | ENSAPLP00000004439, ENSAPLP00000009741 |
| 42 | Ras signaling pathway | ENSAPLP00000001716, ENSAPLP00000013412 |
| 43 | Starch and sucrose metabolism | ENSAPLP00000009741 |
| 44 | Morphine addiction | ENSAPLP00000001716 |
| 45 | MicroRNAs in cancer | ENSAPLP00000016323, ENSAPLP00000013972 |
| 46 | Pathways in cancer | ENSAPLP00000005537, ENSAPLP00000013972, ENSAPLP00000009420, ENSAPLP00000001716 |
| 47 | GABAergic synapse | ENSAPLP00000001716 |
| 48 | Jak-STAT signaling pathway | ENSAPLP00000010107 |
| 49 | Vasopressin-regulated water reabsorption | ENSAPLP00000013412 |
| 50 | Amyotrophic lateral sclerosis (ALS) | ENSAPLP00000012498 |
| 51 | Pancreatic secretion | ENSAPLP00000002717 |
| 52 | Amino sugar and nucleotide sugar metabolism | ENSAPLP00000009741 |
| 53 | Central carbon metabolism in cancer | ENSAPLP00000009741 |
| 54 | Transcriptional misregulation in cancer | ENSAPLP00000013972 |
| 55 | TNF signaling pathway | ENSAPLP00000013972 |
| 56 | Retrograde endocannabinoid signaling | ENSAPLP00000001716 |
| 57 | Prostate cancer (no map in kegg database) | ENSAPLP00000005537 |
| 58 | Salivary secretion | ENSAPLP00000009817 |
| 59 | Glutathione metabolism | ENSAPLP00000005537 |
| 60 | Glutamatergic synapse | ENSAPLP00000001716 |
| 61 | Viral myocarditis | ENSAPLP00000005355 |
| 62 | Gastric acid secretion | ENSAPLP00000002717 |
| 63 | Phagosome | ENSAPLP00000015503, ENSAPLP00000013412 |
| 64 | Circadian entrainment | ENSAPLP00000001716 |
| 65 | Cholinergic synapse | ENSAPLP00000001716 |
| 66 | Prion diseases (no map in kegg database) | ENSAPLP00000016323 |
| 67 | Fatty acid metabolism (no map in kegg database) | ENSAPLP00000004409 |
| 68 | Hippo signaling pathway - fly | ENSAPLP00000002091 |
| 69 | Serotonergic synapse | ENSAPLP00000001716 |
| 70 | Fatty acid degradation | ENSAPLP00000004409 |
| 71 | Cell cycle | ENSAPLP00000002091 |
| 72 | RNA degradation | ENSAPLP00000003473 |
| 73 | Small cell lung cancer | ENSAPLP00000009420 |
| 74 | Salmonella infection | ENSAPLP00000003837 |
| 75 | Gap junction | ENSAPLP00000015503 |
| 76 | Proteasome | ENSAPLP00000015706 |
| 77 | Epstein-Barr virus infection | ENSAPLP00000015706, ENSAPLP00000002091 |
| 78 | Thyroid hormone signaling pathway | ENSAPLP00000016323 |
| 79 | Oocyte meiosis | ENSAPLP00000002091 |
| 80 | Estrogen signaling pathway | ENSAPLP00000013972 |
| 81 | Glycolysis / Gluconeogenesis | ENSAPLP00000009741 |
| 82 | Ribosome | ENSAPLP00000008818, ENSAPLP00000004439 |
| 83 | Valine, leucine and isoleucine degradation | ENSAPLP00000010177 |
| 84 | RNA transport | ENSAPLP00000005355, ENSAPLP00000015971 |
| 85 | Hippo signaling pathway | ENSAPLP00000002091 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ENSAPLP00000012522 |
| 87 | Axon guidance | ENSAPLP00000004714 |
| 88 | Hypertrophic cardiomyopathy (HCM) | ENSAPLP00000012522 |
| 89 | Dopaminergic synapse | ENSAPLP00000001716 |
| 90 | Dilated cardiomyopathy | ENSAPLP00000012522 |
| 91 | Tuberculosis | ENSAPLP00000013412 |
| 92 | Non-alcoholic fatty liver disease (NAFLD) | ENSAPLP00000014609 |
| 93 | Chemokine signaling pathway | ENSAPLP00000001716 |
| 94 | Leukocyte transendothelial migration | ENSAPLP00000013972 |
| 95 | Oxidative phosphorylation | ENSAPLP00000014609 |
| 96 | MAPK signaling pathway | ENSAPLP00000003837 |
| 97 | Rap1 signaling pathway | ENSAPLP00000002523 |
| 98 | Lysosome | ENSAPLP00000004168 |
| 99 | Parkinson's disease | ENSAPLP00000014609 |
| 100 | Alzheimer's disease | ENSAPLP00000014609 |
| 101 | Endocytosis | ENSAPLP00000005705, ENSAPLP00000013412 |
| 102 | Carbon metabolism (no map in kegg database) | ENSAPLP00000009741 |
| 103 | Huntington's disease | ENSAPLP00000014609 |
| 104 | Metabolic pathways (no map in kegg database) | ENSAPLP00000004409, ENSAPLP00000002523, ENSAPLP00000009741, ENSAPLP00000014609 |